EUVIMEDEUVIMED entdecken
Crossref

Sorafenib, a Tyrosine Kinase Inhibitor, Synergistically Enhances the Ferroptosis Effects of Asiatic Acid in Hepatocellular Carcinoma Cells

Yong-Syuan Chen iD, Chien-Hsing Lee, Yi-Hsien Hsieh iD, Hui-Ling Chiou, Ming-Chun Hung, Hsiang-Lin Lee

Environmental Toxicology · 2025-01 · 40 (1) · 79-87

DOI: 10.1002/tox.24415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 12.09.2024. Verfasst von Yong-Syuan Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Sorafenib, Carcinoma, Hepatocellular, Ferroptosis, Pentacyclic Triterpenes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Chung Shan Medical University Hospital, China Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) remains one of the most common cancers worldwide. Asiatic acid (AA) is a natural triterpene, which is recognized as effect of antioxidant and antitumor. Sorafenib (Sor), an orally target drug, has been applicate for the HCC therapy. However, the synergistic effect of AA and Sor on human HCC is still unclear. Here, we explore the effect of combined treatment with AA and Sor in the HCC cell line SK‐HEP‐1 and HepG2. Compared with treating alone, our results demonstrated that AA combined with Sor synergistically inhibited proliferative rates in MTT assay and colony formation assay. We also found that AA combined with Sor in HCC cells strongly caused cell cycle arrest in G0/G1 phase and affected the protein level of cyclin D1 and SKP2. Furthermore, combination treatment strongly enhanced ferroptosis through cellular accumulation of iron ions, lipid peroxidation, and ferroptosis‐related proteins (GPX4 and FTH1) in HCC cells. In addition, the combined treatment resulted in higher phosphorylation of JNK1/2 in the promotion of ferroptosis than drug treatment alone. These results indicate that AA combined with Sor synergistically improved ferroptosis in HCC cells through the regulation of JNK1/2 signaling. Taken together, the combinatorial strategy may serve as the potential treatment in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibCarcinoma, HepatocellularFerroptosisPentacyclic TriterpenesLiver NeoplasmsDrug SynergismHumansCell Line, TumorProtein Kinase InhibitorsAntineoplastic AgentsHep G2 CellsCell ProliferationTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

Asiatic acidferroptosishepatocellular carcinomasorafenib

Substanzen

SorafenibPentacyclic Triterpenesasiatic acidProtein Kinase InhibitorsAntineoplastic AgentsTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Division of Pediatric Surgery, Children's Hospital of China Medical University, Taichung, Taiwan.
  • Department of Surgery, Children's Hospital of China Medical University, Taichung, Taiwan.
  • School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan.
  • School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan.

ORCID-Profile: Yong-Syuan Chen, Yi-Hsien Hsieh

Förderung

  • Chung Shan Medical University Hospital
  • China Medical University Hospital

Zitieren

APA

Chen, Y. S., Lee, C. H., Hsieh, Y. H., Chiou, H. L., Hung, M. C., & Lee, H. L. (2025). Sorafenib, a Tyrosine Kinase Inhibitor, Synergistically Enhances the Ferroptosis Effects of Asiatic Acid in Hepatocellular Carcinoma Cells. Environmental Toxicology, 40(1), 79-87. https://doi.org/10.1002/tox.24415

Vancouver

Chen YS, Lee CH, Hsieh YH, Chiou HL, Hung MC, Lee HL. Sorafenib, a Tyrosine Kinase Inhibitor, Synergistically Enhances the Ferroptosis Effects of Asiatic Acid in Hepatocellular Carcinoma Cells. Environmental Toxicology. 2025;40(1):79-87. doi:10.1002/tox.24415

BibTeX
@article{Chen2025,
  author = {Chen, Yong-Syuan and Lee, Chien-Hsing and Hsieh, Yi-Hsien and Chiou, Hui-Ling and Hung, Ming-Chun and Lee, Hsiang-Lin},
  title = {Sorafenib, a Tyrosine Kinase Inhibitor, Synergistically Enhances the Ferroptosis Effects of Asiatic Acid in Hepatocellular Carcinoma Cells},
  journal = {Environmental Toxicology},
  year = {2025},
  volume = {40},
  number = {1},
  pages = {79--87},
  doi = {10.1002/tox.24415}
}
Kostenlos starten →